Cardiometabolic & kidneyGuideline or statement
Implementing sodium–glucose co-transporter 2 inhibitors in cardiovascular–kidney–metabolic syndrome: a multidisciplinary expert perspective
- expert opinion
- multidisciplinary Italian board
- informal multidisciplinary roundtable discussions
Recommendations
As issued by the authors
early risk-based screening
simplified treatment algorithms
cross-specialty collaboration
educational efforts to empower both clinicians and patients
Original publication
Implementing sodium–glucose co-transporter 2 inhibitors in cardiovascular–kidney–metabolic syndrome: a multidisciplinary expert perspective. Eur Heart J Cardiovasc Pharmacother. Published 10 April 2026. doi:10.1093/ehjcvp/pvag020
Summarised from the published abstract; every number is checked against it